BioCentury
ARTICLE | Clinical News

Brinzolamide/brimonidine tartrate regulatory update

July 30, 2012 7:00 AM UTC

Novartis disclosed in its 2Q12 earnings that its Alcon Inc. ophthalmic unit filed a regulatory application in the U.S. for brinzolamide/brimonidine tartrate to treat intraocular pressure in patients ...